Clinical trial
A Trial of an Investigational Drug for the Prevention of Diarrhea Associated…
NCT00040391 · Celgene Corporation, Industry · Terminated
Key facts
| NCT number | NCT00040391 |
|---|---|
| Title | A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer |
| Official title | A Phase II, Randomized, Open-label, Controlled, Dose-elevation, Multicenter Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer |
| Lead sponsor | Celgene Corporation, Industry |
| Collaborators | Pfizer Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Neoplasms, Diarrhea |
| Intervention type | Drug |
| Interventions | Investigational drug, Irinotecan, 5-fluorouracil, Leucovorin |
| Start date | Jun 1, 2002 |
| First posted | Jun 27, 2002 |
| Last update posted | Dec 1, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: